Total Funding
21
Total FundingSeries B raised
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
135786
OriCiro Genomics develops and commercializes cell-free synthesis and amplification technologies of large DNA molecules.
- Hirasaki Seiji: President and CEO
- Shigemasa (Shige) Sasaki: COO & CBO
About the Company
OriCiro Genomics creates a better bioeconomy with innovative genome technologies. The company is a pioneer in cell-free synthesis and amplification of genome-scale large DNA for synthetic biology.
The company creates a technology that covers "DNA assembly" and "circular DNA amplification", allowing to construct large circular
DNA molecules without relying on conventional biological cloning.
